When do institutional investors invest into biotech ?Institutional investors tend to invest in the biotechnology sector at various stages of a company's development, depending on their investment strategy and risk tolerance.
They may invest in early-stage biotech companies that are still in the research and development phase, in mid-stage companies that have a promising product or technology but are still in clinical trials, or in late-stage companies that have already received regulatory approval and are commercializing their products.
Institutional investors may also invest in publicly traded biotech companies that have a proven track record and are generating revenue. The timing of an institutional investor's investment in the biotech sector is influenced by several factors, including the overall market conditions, the performance of the biotech industry, the company's progress and financial position, and regulatory developments.
these are facts